These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 6814000)

  • 1. Homo- and heterogeneous forms of human factor VIII.
    Vukovich TC
    Thromb Haemost; 1982 Aug; 48(1):98-100. PubMed ID: 6814000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of human factor VIII/vWF in lipaemic plasma.
    Vukovich T; Marktl M; Nemeth G
    Thromb Res; 1985 May; 38(3):215-24. PubMed ID: 3927507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneity of human factor VIII. I. Characterization of factor VIII present in the supernatant of cryoprecipitate.
    Over J; Bouma BN; van Mourik JA; Sixma JJ; Vlooswijk R; Bakker-Woudenberg I
    J Lab Clin Med; 1978 Jan; 91(1):32-46. PubMed ID: 618989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gel filtration patterns of factor VIII coagulant antigen and factor VIII related antigen in normal and von Willebrand's disease.
    Chediak J; Peake I; Bloom A
    Thromb Haemost; 1983 Aug; 50(2):509-12. PubMed ID: 6415844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of factor VIII procoagulant antigen VIII:CAg and factor VIII related antigen VIIIR:Ag by EDTA - influence of divalent cation on the binding of VIII:CAg and VIIIR:Ag.
    Tran TH; Duckert F
    Thromb Haemost; 1983 Aug; 50(2):547-51. PubMed ID: 6415848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterogeneity of molecular size of factor VIII/von Willebrand factor in von Willbrand's disease.
    Mikami S; Takahashi Y; Nishino M; Okubo Y; Fukui H
    Thromb Haemost; 1981 Jun; 45(3):272-5. PubMed ID: 6792740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
    Over J; Bouma BN; Sixma JJ; Bolhuis PA; Vlooswijk RA
    J Lab Clin Med; 1980 Mar; 95(3):323-34. PubMed ID: 7354239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standardization of Factor VIII-III. Establishment of a stable reference plasma for Factor VIII-related activities.
    Barrowcliffe TW; Tydeman MS; Kirkwood TB; Thomas DP
    Thromb Haemost; 1983 Oct; 50(3):690-6. PubMed ID: 6417818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of factor VIII related protein synthesized by human endothelial cell: a study of structure and function.
    Chan V; Chan TK
    Thromb Haemost; 1982 Oct; 48(2):177-81. PubMed ID: 6817445
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIII-related activities in therapeutic concentrates.
    Barrowcliffe TW; Kemball-Cook G; Morris G; Holt JC; Furlong RA; Peake IR
    J Lab Clin Med; 1981 Mar; 97(3):429-38. PubMed ID: 6780643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factor VIII: C and factor VIII R: Ag in Argentine hemorrhagic fever.
    Molinas FC; Maiztegui JI
    Thromb Haemost; 1981 Aug; 46(2):525-7. PubMed ID: 6795740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of plasma fibronectin (cold-insoluble globulin) and components of the factor VIII complex after heparin-induced precipitation of plasma.
    Amrani DL; Mosesson MW; Hoyer LW
    Blood; 1982 Mar; 59(3):657-63. PubMed ID: 6800421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multimeric structure of factor VIII/von Willebrand factor in von Willebrand's disease.
    Meyer D; Obert B; Pietu G; Lavergne JM; Zimmerman TS
    J Lab Clin Med; 1980 Apr; 95(4):590-602. PubMed ID: 6965697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
    Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
    Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
    Budde U; Drewke E
    Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of the factor VIII complex.
    Thorell L; Blombäck B
    Thromb Res; 1984 Aug; 35(4):431-50. PubMed ID: 6435279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.
    Over J; Sixma JJ; Bruïne MH; Trieschnigg MC; Vlooswijk RA; Beeser-Visser NH; Bouma BN
    J Clin Invest; 1978 Aug; 62(2):223-34. PubMed ID: 670391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586).
    Hubbard AR; Rigsby P; Barrowcliffe TW
    Thromb Haemost; 2001 Apr; 85(4):634-8. PubMed ID: 11341497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factor VIII complex activities in acute leukemia].
    Pniejnia-Olszyński W; Lopaciuk S
    Acta Haematol Pol; 1980; 11(4):239-47. PubMed ID: 6794320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of cryoprecipitate of intermediate purity in a closed system thaw-siphon process.
    Mason EC; Pepper DS; Griffin B
    Thromb Haemost; 1981 Aug; 46(2):543-6. PubMed ID: 6795742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.